By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


GW Pharmaceuticals Ltd. 

Porton Down Science Park

Salisbury  Wiltshire  SP4 0JQ  United Kingdom
Phone: 44-1980-619000 Fax: +44-1980-619111



Company News
GW Pharma (GWPH) Announces Date And Time Change For Q4 And Year-End 2015 Financial Results And Conference Call 11/30/2015 8:33:02 AM
GW Pharma (GWPH) Release: New Epidiolex (CBD) Data Accepted For Presentation At The 69th Annual Meeting Of The American Epilepsy Society 11/25/2015 7:56:29 AM
GW Pharma (GWPH) To Report Q4 And Year-End 2015 Financial Results And Host Conference Call On 3 December, 2015 11/25/2015 7:54:03 AM
GW Pharma (GWPH) To Present At The Piper Jaffray 27th Annual Healthcare Conference 11/25/2015 7:46:27 AM
GW Pharma (GWPH), NSW to Host World's First Cannabis Trial for Epileptic Children 10/27/2015 5:59:56 AM
GW Pharma (GWPH)'s Sativev Disappoints in Two Late-Stage Cancer Pain Trials 10/27/2015 5:55:11 AM
GW Pharma (GWPH) Surges on Positive Phase II Cannabis-Based Drug Study for Schizophrenia and Some Rare Diseases 9/15/2015 10:11:53 AM
GW Pharma (GWPH) To Present At Two Upcoming Investor Conferences 9/10/2015 11:00:30 AM
GW Pharma (GWPH) Receives FDA Fast Track And European Medicines Agency Orphan Designations For Intravenous Cannabidiol In The Treatment Of Neonatal Hypoxic-Ischemic Encephalopathy (NHIE) 8/6/2015 11:01:41 AM
GW Pharma (GWPH) Reports Third Quarter 2015 Financial Results And Operational Progress 8/6/2015 10:50:56 AM